Reduced intensity treatment in early-stage Hodgkin’s lymphoma
Prathima Prodduturi, James O ArmitageUniversity of Nebraska Medical Center, Omaha, NE, USAAbstract: Early-stage Hodgkin’s lymphoma which includes patients with Ann Arbor stages I or II, accounts for more than 50% of all cases of the illness and is curable in a high proportion of patien...
Saved in:
Main Authors: | Armitage JO, Prodduturi P |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2011
|
Subjects: | |
Online Access: | https://doaj.org/article/c4f4e07d307e47caa9d5db84f40d0989 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
mTOR inhibitor in the treatment of Hodgkin’s lymphoma: a case report
by: Provencio M., et al.
Published: (2011) -
MEDICAL TREATMENT IN HODGKIN LYMPHOMA
by: Nilgun Kurucu
Published: (2021) -
ANTICARDIOLIPINIC ANTIBODIES IN NON-HODGKIN LYMPHOMA
by: Sanda Buruiana, et al.
Published: (2021) -
Intrasinusoidal Hodgkin Lymphoma; A Mimic of Anaplastic Large Cell Lymphoma
by: John R. Krause, et al.
Published: (2021) -
MicroRNA dysregulation in B-cell non-Hodgkin lymphoma
by: Lim EL, et al.
Published: (2013)